Ask AI

Precision in Practice: Implementing HER2 Testing and HER2-Directed Therapy in Gynecologic Cancers

Enhance your ability to deliver patient-centered, evidence-based, biomarker-informed treatment for patients with gynecologic cancers, with a focus on HER2 testing and HER2-directed therapies, through an expert-authored ClinicalThought commentary and certified on-demand webcast with accompanying downloadable slides.

Share

Program Content

Events

Activities

HER2 Testing and Therapy in Gynecologic Cancers
Precision in Practice: Implementing HER2 Testing and HER2-Directed Therapy in Gynecologic Cancers
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: August 20, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education.

Supporters

This activity is supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.